Oct. 17 at 11:13 PM
$OCUL @Aaronpell To reply to your message in which you mentioned that after-hours trading is meaningless and not important, I completely understand your point of view as a highly knowledgeable expert — and, of course, as a sharp analyst. It’s just that when the average after-hours trading volume jumps from around 21,220 shares over the past two years to more than 400,000 for ten consecutive sessions — even with a sizable shelf offering — some of us can’t help but find that a little intriguing. I perfectly understand that, from your elevated standpoint, such things might appear irrelevant. But for those of us who are perhaps a bit less brilliant, yet still fairly familiar with how biotech names behave, it’s rather hard not to notice.
